Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
September 11, 2023 7:59 AM 4 min read

Leafly's Take: Cannabis Reclassification, Consumer Choices And The Budtender Connection

by Nicolás Jose Rodriguez Benzinga Staff Writer
Follow

ArticleFeaturedTickersList12345!!!

In an exclusive interview with Benzinga, Carlos Pinto, chief commercial officer (CCO) of Leafly Holdings Inc. (NASDAQ:LFLY) discussed the strategic shift the cannabis marketplace and education platform has undergone. He also shared his perspective on the Department of Health and Human Services (HHS) recent recommendation to reclassify cannabis from Schedule I to Schedule III. 

Leafly's Transformation: From Cannabis News To A Thriving Marketplace

Carlos Pinto, an expert in commercialization will be a featured speaker at the upcoming Benzinga Cannabis Capital Conference in Chicago on September 27 - 28. 

Recognized as a cannabis industry news agency, Leafly is undergoing a transformative shift into a dynamic marketplace that caters to consumer education and product preferences. Pinto said their focus has evolved beyond news reporting to delivering essential information about cannabis strains, products, and user reviews.

He underscored Leafly's recent partnership with GetGreenlane and its significance for the B2B sector streamlining processes for retailers and ensuring real-time inventory synchronization.

Cannabis Content Preferences: A Shift Towards Education And Market Engagement

Pinto explained Leafly’s shift from news-centric to education-focused cannabis content, propelled by factors such as maturing legal markets and evolving consumer demographics. He referred to certain trends influencing these changes in consumption and branding:

  • In fully legalized cannabis markets, consumers are now showing a growing interest in informative content encompassing strain details, product trends, and consumption methods.
  • There is a noteworthy demographic shift, with a growing population aged 55 and above engaging with or exploring cannabis.
  • Even in illicit cannabis markets, Leafly's educational content remains popular and helps consumers make informed decisions.
  • The cannabis market exhibits localized and fragmented behavior, with consumer preferences varying between neighboring states.
  • Cannabis oversupply issues can impact prices and the illicit market in other states.
  • This diversity presents a challenge in adapting the platform to cater to individual market preferences.

In this context, Leafly aims to provide robust data for informed product choices and industry standardization while addressing information gaps and catering to diverse demographics.

Subtle Optimism And Caution: Cannabis Industry's Regulatory Shift

Leafly’s CCO acknowledged the positive step forward this represents for the industry but emphasized the complexity of the situation.

While the potential reclassification of cannabis under FDA regulation is cause for celebration, Pinto pointed out the uncertainties that loom, such as the extent of FDA influence and the potential overwrite of existing state regulations.

Pinto cautiously argued that the recommendation would likely pass in February and anticipated increased federal funding for research and possibly faster progress on the SAFE Act.

However, he is cautiously optimistic about the pharmaceutical industry's role, highlighting both the benefits, such as rigorous research and compliance, and concerns about cannabis becoming overly pharmaceutical.

Unlocking the Future of Cannabis Branding in The Digital Landscape - A Preview Of The Next Benzinga CCC

In addition, Pinto provided an exclusive glimpse into the upcoming Benzinga Cannabis Capital Conference's discussion on building a robust digital presence for cannabis brands.

The Benzinga Cannabis Capital Conference, where deals get done, is returning to Chicago this September 27 - 28. Do not miss the opportunity to attend the most important conference for cannabis investors.

He noted that brands are increasingly focused on creating their ecosystems to engage consumers from the initial journey to building long-term loyalty. This evolving strategy necessitates the integration of brands, products and retailers to provide consumers with the best possible experience.

Budtender Connection 

Drawing an analogy from the retail segment, where budtenders have a significant influence on consumer choices, Pinto explained that Leafly strives to act as the "connective tissue" between brands and retailers.

The Benzinga Cannabis Capital Conference promises to delve deeper into these transformative strategies, offering valuable insights for cannabis brands aiming to excel in the digital era. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.

Photo by Joe Pee on Unsplash. 

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
CannabisNewsPenny StocksEmerging MarketsCommoditiesRetail SalesManagementExclusivesMarketsInterviewDEAHHSLeafly
LFLY Logo
LFLYLeafly Holdings Inc
$0.2710-99.9%
Overview

"These are good news, but there is a lot more complexity behind all of this. This is still very early in the game, and we just don't know the extent of the regulation or influence that the FDA will exert over the entire industry. We're uncertain whether the FDA might revise some of the regulations in individual markets, leaving us with more questions than answers at this stage," he said. "On the positive side, if this passes—and I believe it will, possibly in February—it could secure additional federal funding for research and potentially expedite the SAFE Act, opening new opportunities for the entire industry."

"Think of it like going to a bar and searching for your favorite drink. Sometimes, they don't have your preferred brand, but you ask the bartender for their recommendation as an alternative. What we've discovered is that budtenders at retail cannabis stores wield significant influence over consumer choices. Our role at Leafly is to connect the unique qualities of these products to the bartenders through education and by providing the necessary data to assist them in advising consumers. This, in turn, helps brands cultivate loyal consumers for their products."

LFLY Logo
LFLYLeafly Holdings Inc
$0.2710-99.9%
Overview
Comments
Loading...